OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab
Tatsuya Kikuchi, Yasuto Takeuchi, Kazuhiro Nouso, et al.
Liver International (2024) Vol. 44, Iss. 6, pp. 1456-1463
Open Access | Times Cited: 7
Tatsuya Kikuchi, Yasuto Takeuchi, Kazuhiro Nouso, et al.
Liver International (2024) Vol. 44, Iss. 6, pp. 1456-1463
Open Access | Times Cited: 7
Showing 7 citing articles:
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
Shigeo Shimose, Issei Saeki, Takanori Ito, et al.
Hepatology International (2025)
Closed Access
Shigeo Shimose, Issei Saeki, Takanori Ito, et al.
Hepatology International (2025)
Closed Access
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, et al.
Alimentary Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 3
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, et al.
Alimentary Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 3
Depth and Duration of Response Are Associated With Survival in Patients With Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150
Masatoshi Kudo, Tatsuya Yamashita, Richard S. Finn, et al.
Liver Cancer (2025), pp. 1-24
Open Access
Masatoshi Kudo, Tatsuya Yamashita, Richard S. Finn, et al.
Liver Cancer (2025), pp. 1-24
Open Access
Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab
Bing Chen, Bojie Huang
Liver International (2024) Vol. 44, Iss. 7, pp. 1735-1735
Closed Access | Times Cited: 1
Bing Chen, Bojie Huang
Liver International (2024) Vol. 44, Iss. 7, pp. 1735-1735
Closed Access | Times Cited: 1
Aggressive Multidisciplinary Treatment for Unresectable Hepatocellular Carcinoma: The Achievement of a Pathologic Complete Response and Long-Term Survival
Takuma Karasuyama, Takamichi Ishii, Tomoaki Yoh, et al.
Annals of Surgical Oncology (2024)
Closed Access | Times Cited: 1
Takuma Karasuyama, Takamichi Ishii, Tomoaki Yoh, et al.
Annals of Surgical Oncology (2024)
Closed Access | Times Cited: 1
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response cases.
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, et al.
Research Square (Research Square) (2024)
Open Access
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, et al.
Research Square (Research Square) (2024)
Open Access
Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response
Teiji Kuzuya, Naoto Kawabe, Hisanori Muto, et al.
Current Oncology (2024) Vol. 31, Iss. 10, pp. 6218-6231
Open Access
Teiji Kuzuya, Naoto Kawabe, Hisanori Muto, et al.
Current Oncology (2024) Vol. 31, Iss. 10, pp. 6218-6231
Open Access
ASO Author Reflections: The Role of Salvage Surgery in Multidisciplinary Treatment for Unresectable Advanced Hepatocellular Carcinoma
Takuma Karasuyama, Takamichi Ishii, Tomoaki Yoh, et al.
Annals of Surgical Oncology (2024)
Closed Access
Takuma Karasuyama, Takamichi Ishii, Tomoaki Yoh, et al.
Annals of Surgical Oncology (2024)
Closed Access
